Revenue (TTM) Chart

View Revenue (TTM) for IKTSY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 4.738B
December 31, 2025 4.524B
June 30, 2025 4.394B
December 31, 2024 4.337B
June 30, 2024 4.228B
December 31, 2023 4.138B
June 30, 2023 4.020B
December 31, 2022 3.931B
June 30, 2022 3.935B
December 31, 2021 3.831B
June 30, 2021 3.672B
December 31, 2020 3.518B
June 30, 2020 3.620B
December 31, 2019 3.810B
June 30, 2019 3.748B
December 31, 2018 3.735B
June 30, 2018 3.694B
December 31, 2017 3.568B
June 30, 2017 3.468B
December 31, 2016 3.464B
June 30, 2016 3.420B
December 31, 2015 3.310B
June 30, 2015 3.352B
December 31, 2014 3.447B
Date Value
June 30, 2014 3.451B
December 31, 2013 3.415B
June 30, 2013 3.367B
December 31, 2012 3.256B
June 30, 2012 3.131B
December 31, 2011 2.802B
June 30, 2011 2.362B
December 31, 2010 2.123B
June 30, 2010 2.000B
December 31, 2009 1.944B
June 30, 2009 1.874B
December 31, 2008 1.844B
June 30, 2008 1.752B
December 31, 2007 1.557B
June 30, 2007 1.358B
December 31, 2006 1.234B
June 30, 2006 1.130B
December 31, 2005 1.050B
June 30, 2005 993.41M
December 31, 2004 917.28M
June 30, 2004 838.51M
December 31, 2003 775.49M
June 30, 2003 733.49M
December 31, 2002 695.94M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Capita Plc 2.614B
ALS Ltd. 2.195B
RWS Holdings Plc 946.19M
Elixirr International Plc 197.30M
Exponent, Inc. 632.46M